IBDEI2IF ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,40077,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40077,1,3,0)
;;=3^Gout,Unspec
;;^UTILITY(U,$J,358.3,40077,1,4,0)
;;=4^M10.9
;;^UTILITY(U,$J,358.3,40077,2)
;;=^5010404
;;^UTILITY(U,$J,358.3,40078,0)
;;=G90.59^^152^2006^35
;;^UTILITY(U,$J,358.3,40078,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40078,1,3,0)
;;=3^Complex Regional Pain Syndrome I,Unspec
;;^UTILITY(U,$J,358.3,40078,1,4,0)
;;=4^G90.59
;;^UTILITY(U,$J,358.3,40078,2)
;;=^5004171
;;^UTILITY(U,$J,358.3,40079,0)
;;=G56.01^^152^2006^13
;;^UTILITY(U,$J,358.3,40079,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40079,1,3,0)
;;=3^Carpal Tunnel Syndrome,Right Upper Limb
;;^UTILITY(U,$J,358.3,40079,1,4,0)
;;=4^G56.01
;;^UTILITY(U,$J,358.3,40079,2)
;;=^5004018
;;^UTILITY(U,$J,358.3,40080,0)
;;=G56.02^^152^2006^12
;;^UTILITY(U,$J,358.3,40080,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40080,1,3,0)
;;=3^Carpal Tunnel Syndrome,Left Upper Limb
;;^UTILITY(U,$J,358.3,40080,1,4,0)
;;=4^G56.02
;;^UTILITY(U,$J,358.3,40080,2)
;;=^5004019
;;^UTILITY(U,$J,358.3,40081,0)
;;=G56.21^^152^2006^60
;;^UTILITY(U,$J,358.3,40081,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40081,1,3,0)
;;=3^Lesion of Ulnar Nerve,Right Upper Limb
;;^UTILITY(U,$J,358.3,40081,1,4,0)
;;=4^G56.21
;;^UTILITY(U,$J,358.3,40081,2)
;;=^5004024
;;^UTILITY(U,$J,358.3,40082,0)
;;=G56.22^^152^2006^59
;;^UTILITY(U,$J,358.3,40082,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40082,1,3,0)
;;=3^Lesion of Ulnar Nerve,Left Upper Limb
;;^UTILITY(U,$J,358.3,40082,1,4,0)
;;=4^G56.22
;;^UTILITY(U,$J,358.3,40082,2)
;;=^5004025
;;^UTILITY(U,$J,358.3,40083,0)
;;=L40.52^^152^2006^143
;;^UTILITY(U,$J,358.3,40083,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40083,1,3,0)
;;=3^Psoriatic Arthritis Mutilans
;;^UTILITY(U,$J,358.3,40083,1,4,0)
;;=4^L40.52
;;^UTILITY(U,$J,358.3,40083,2)
;;=^5009167
;;^UTILITY(U,$J,358.3,40084,0)
;;=L40.53^^152^2006^144
;;^UTILITY(U,$J,358.3,40084,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40084,1,3,0)
;;=3^Psoriatic Spondylitis
;;^UTILITY(U,$J,358.3,40084,1,4,0)
;;=4^L40.53
;;^UTILITY(U,$J,358.3,40084,2)
;;=^5009168
;;^UTILITY(U,$J,358.3,40085,0)
;;=M32.9^^152^2006^187
;;^UTILITY(U,$J,358.3,40085,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40085,1,3,0)
;;=3^Systemic Lupus Erythematosus,Unspec
;;^UTILITY(U,$J,358.3,40085,1,4,0)
;;=4^M32.9
;;^UTILITY(U,$J,358.3,40085,2)
;;=^5011761
;;^UTILITY(U,$J,358.3,40086,0)
;;=M32.0^^152^2006^183
;;^UTILITY(U,$J,358.3,40086,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40086,1,3,0)
;;=3^Systemic Lupus Erythematosus,Drug-Induced
;;^UTILITY(U,$J,358.3,40086,1,4,0)
;;=4^M32.0
;;^UTILITY(U,$J,358.3,40086,2)
;;=^5011752
;;^UTILITY(U,$J,358.3,40087,0)
;;=M32.13^^152^2006^185
;;^UTILITY(U,$J,358.3,40087,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40087,1,3,0)
;;=3^Systemic Lupus Erythematosus,Lung Involvement
;;^UTILITY(U,$J,358.3,40087,1,4,0)
;;=4^M32.13
;;^UTILITY(U,$J,358.3,40087,2)
;;=^5011756
;;^UTILITY(U,$J,358.3,40088,0)
;;=M32.14^^152^2006^184
;;^UTILITY(U,$J,358.3,40088,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40088,1,3,0)
;;=3^Systemic Lupus Erythematosus,Glomerular Disease
;;^UTILITY(U,$J,358.3,40088,1,4,0)
;;=4^M32.14
;;^UTILITY(U,$J,358.3,40088,2)
;;=^5011757
;;^UTILITY(U,$J,358.3,40089,0)
;;=M32.12^^152^2006^186
;;^UTILITY(U,$J,358.3,40089,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2IF 3791 printed Dec 13, 2024@02:29:21 Page 2
IBDEI2IF ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,40077,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,40077,1,3,0)
+4 ;;=3^Gout,Unspec
+5 ;;^UTILITY(U,$J,358.3,40077,1,4,0)
+6 ;;=4^M10.9
+7 ;;^UTILITY(U,$J,358.3,40077,2)
+8 ;;=^5010404
+9 ;;^UTILITY(U,$J,358.3,40078,0)
+10 ;;=G90.59^^152^2006^35
+11 ;;^UTILITY(U,$J,358.3,40078,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,40078,1,3,0)
+14 ;;=3^Complex Regional Pain Syndrome I,Unspec
+15 ;;^UTILITY(U,$J,358.3,40078,1,4,0)
+16 ;;=4^G90.59
+17 ;;^UTILITY(U,$J,358.3,40078,2)
+18 ;;=^5004171
+19 ;;^UTILITY(U,$J,358.3,40079,0)
+20 ;;=G56.01^^152^2006^13
+21 ;;^UTILITY(U,$J,358.3,40079,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,40079,1,3,0)
+24 ;;=3^Carpal Tunnel Syndrome,Right Upper Limb
+25 ;;^UTILITY(U,$J,358.3,40079,1,4,0)
+26 ;;=4^G56.01
+27 ;;^UTILITY(U,$J,358.3,40079,2)
+28 ;;=^5004018
+29 ;;^UTILITY(U,$J,358.3,40080,0)
+30 ;;=G56.02^^152^2006^12
+31 ;;^UTILITY(U,$J,358.3,40080,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,40080,1,3,0)
+34 ;;=3^Carpal Tunnel Syndrome,Left Upper Limb
+35 ;;^UTILITY(U,$J,358.3,40080,1,4,0)
+36 ;;=4^G56.02
+37 ;;^UTILITY(U,$J,358.3,40080,2)
+38 ;;=^5004019
+39 ;;^UTILITY(U,$J,358.3,40081,0)
+40 ;;=G56.21^^152^2006^60
+41 ;;^UTILITY(U,$J,358.3,40081,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,40081,1,3,0)
+44 ;;=3^Lesion of Ulnar Nerve,Right Upper Limb
+45 ;;^UTILITY(U,$J,358.3,40081,1,4,0)
+46 ;;=4^G56.21
+47 ;;^UTILITY(U,$J,358.3,40081,2)
+48 ;;=^5004024
+49 ;;^UTILITY(U,$J,358.3,40082,0)
+50 ;;=G56.22^^152^2006^59
+51 ;;^UTILITY(U,$J,358.3,40082,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,40082,1,3,0)
+54 ;;=3^Lesion of Ulnar Nerve,Left Upper Limb
+55 ;;^UTILITY(U,$J,358.3,40082,1,4,0)
+56 ;;=4^G56.22
+57 ;;^UTILITY(U,$J,358.3,40082,2)
+58 ;;=^5004025
+59 ;;^UTILITY(U,$J,358.3,40083,0)
+60 ;;=L40.52^^152^2006^143
+61 ;;^UTILITY(U,$J,358.3,40083,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,40083,1,3,0)
+64 ;;=3^Psoriatic Arthritis Mutilans
+65 ;;^UTILITY(U,$J,358.3,40083,1,4,0)
+66 ;;=4^L40.52
+67 ;;^UTILITY(U,$J,358.3,40083,2)
+68 ;;=^5009167
+69 ;;^UTILITY(U,$J,358.3,40084,0)
+70 ;;=L40.53^^152^2006^144
+71 ;;^UTILITY(U,$J,358.3,40084,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,40084,1,3,0)
+74 ;;=3^Psoriatic Spondylitis
+75 ;;^UTILITY(U,$J,358.3,40084,1,4,0)
+76 ;;=4^L40.53
+77 ;;^UTILITY(U,$J,358.3,40084,2)
+78 ;;=^5009168
+79 ;;^UTILITY(U,$J,358.3,40085,0)
+80 ;;=M32.9^^152^2006^187
+81 ;;^UTILITY(U,$J,358.3,40085,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,40085,1,3,0)
+84 ;;=3^Systemic Lupus Erythematosus,Unspec
+85 ;;^UTILITY(U,$J,358.3,40085,1,4,0)
+86 ;;=4^M32.9
+87 ;;^UTILITY(U,$J,358.3,40085,2)
+88 ;;=^5011761
+89 ;;^UTILITY(U,$J,358.3,40086,0)
+90 ;;=M32.0^^152^2006^183
+91 ;;^UTILITY(U,$J,358.3,40086,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,40086,1,3,0)
+94 ;;=3^Systemic Lupus Erythematosus,Drug-Induced
+95 ;;^UTILITY(U,$J,358.3,40086,1,4,0)
+96 ;;=4^M32.0
+97 ;;^UTILITY(U,$J,358.3,40086,2)
+98 ;;=^5011752
+99 ;;^UTILITY(U,$J,358.3,40087,0)
+100 ;;=M32.13^^152^2006^185
+101 ;;^UTILITY(U,$J,358.3,40087,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,40087,1,3,0)
+104 ;;=3^Systemic Lupus Erythematosus,Lung Involvement
+105 ;;^UTILITY(U,$J,358.3,40087,1,4,0)
+106 ;;=4^M32.13
+107 ;;^UTILITY(U,$J,358.3,40087,2)
+108 ;;=^5011756
+109 ;;^UTILITY(U,$J,358.3,40088,0)
+110 ;;=M32.14^^152^2006^184
+111 ;;^UTILITY(U,$J,358.3,40088,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,40088,1,3,0)
+114 ;;=3^Systemic Lupus Erythematosus,Glomerular Disease
+115 ;;^UTILITY(U,$J,358.3,40088,1,4,0)
+116 ;;=4^M32.14
+117 ;;^UTILITY(U,$J,358.3,40088,2)
+118 ;;=^5011757
+119 ;;^UTILITY(U,$J,358.3,40089,0)
+120 ;;=M32.12^^152^2006^186
+121 ;;^UTILITY(U,$J,358.3,40089,1,0)
+122 ;;=^358.31IA^4^2
